Cedars-Sinai investigators have discovered a signaling interaction between two proteins in cells that controls fat ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A study reveals significant liver health improvements in patients.

Discover a study presented at EASL 2025 that suggests that lifestyle factors beyond alcohol play a more substantial role in fatty liver.

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

Cases of alcohol-related liver disease in Andhra Pradesh doubled between 2019 and 2024 when YS Jagan Mohan Reddy was the ...

Let’s explore. Fatty liver disease is divided into two main types: Non-alcoholic fatty liver disease (NAFLD) and Alcoholic fatty liver disease (AFLD). NAFLD, which is not caused by alcohol ...

Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...

Altimmune is exploring future indications, including alcohol-related liver disease (ALD). The company maintains a strong cash position to support ongoing research and development. The trial ...

The leading causes of chronic liver disease globally, ALD and non-alcoholic fatty liver disease (NAFLD), while sharing similar histological features such as steatosis and inflammation, differ in ...

The goals of nutritional therapy are to improve PCM and correct nutrient deficiencies. This can be accomplished via oral, enteral, or parenteral methods, or a combination of these modalities ...